Rizatriptan Benzoate Tablet, Orally Disintegrating
Product Images NDC 71205-398

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 71205-398). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (269f0768 2e6c 4188 Ba86 2d7420d31a21 01)

Chemical structure diagram of Rizatriptan Benzoate, depicting its molecular framework with various rings and functional groups including a carboxyl group.*

FDA Label Image

Estimated Probability Of Achieving An Initial Headache Response By 2 Hours In Pooled Studies 1, 2, 3, And 4 (269f0768 2e6c 4188 Ba86 2d7420d31a21 02)

A line graph showing the estimated probability of response over time post-dose for Rizatriptan Benzoate Tablets, USP 5 mg and 10 mg, compared to placebo. The x-axis represents hours post-dose from 0 to 2, while the y-axis shows the estimated probability of response from 0% to 100%. Rizatriptan 10 mg shows the highest probability of response, followed by 5 mg, with placebo showing the lowest response.*

FDA Label Image

Estimated Probablity Of Remedication Or Response Vs. Hrs Post-dose For Rizatriptan Tablets (269f0768 2e6c 4188 Ba86 2d7420d31a21 03)

A line graph depicting the estimated probability of remediation or rescue over 24 hours post-dose for Rizatriptan Benzoate Tablets at 5 mg and 10 mg strengths compared to placebo. The x-axis represents hours post-dose, and the y-axis represents the probability percentage, showing different response curves for placebo, 5 mg, and 10 mg Rizatriptan Benzoate.*

FDA Label Image

Estimated Probablity Of Response Vs. Hrs Post-dose For Rizatriptan Odt (269f0768 2e6c 4188 Ba86 2d7420d31a21 04)

A line graph displaying the estimated probability of response over time (hours post-dose) for Rizatriptan Benzoate orally disintegrating tablets at 5 mg and 10 mg doses versus placebo. The graph shows response rates increasing from 0 to 2 hours post-dose, with the 10 mg dose having the highest estimated response, followed by the 5 mg dose, and placebo the lowest.*

FDA Label Image

Estimated Probablity Of Remedication Of Rescue Vs. Hrs Post-dose For Rizatriptan Odt (269f0768 2e6c 4188 Ba86 2d7420d31a21 05)

This chart depicts the estimated probability of remediation or rescue over 24 hours post-dose for Rizatriptan Benzoate Orally Disintegrating Tablets USP at 5 mg and 10 mg doses compared to placebo. The x-axis shows hours post-dose, while the y-axis displays the probability percentage. Three curves represent placebo, 5 mg, and 10 mg doses.*

FDA Label Image

Observed Percentage Versus Hours Post Stage 2 Dose (269f0768 2e6c 4188 Ba86 2d7420d31a21 06)

A line graph comparing response percentages over time between Rizatriptan Benzoate Orally Disintegrating Tablets, USP, and placebo. The x-axis shows hours post stage 2 dose (0.5 to 2.0 hours), and the y-axis shows percent (0 to 100) with 95% confidence intervals indicated. The Rizatriptan line shows a higher percentage response than placebo at each time point.*

FDA Label Image

Company Logo (269f0768 2e6c 4188 Ba86 2d7420d31a21 07)

FDA Label Image

Company Logo (269f0768 2e6c 4188 Ba86 2d7420d31a21 08)

FDA Label Image

71205-398-06 (269f0768 2e6c 4188 Ba86 2d7420d31a21 10)

Label for Rizatriptan Benzoate ODT 10 mg orally disintegrating tablets by Proficient Rx LP, NDC 71205-398-06. The label states the product is prescription only and includes details such as tablet count (1x6), active ingredient strength, physical description of the tablets, manufacturer information (Unichem Laboratories Ltd., India), storage instructions, and safety warnings. Multiple QR codes and lot/expiration placeholders are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.